{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:14:19Z","timestamp":1780514059053,"version":"3.54.1"},"reference-count":20,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Backgrounds\/Objectives: Trabeculectomy is the gold standard for glaucoma drainage surgery, but it is associated with a risk of sight-threatening complications. The PreserFlo MicroShunt (PF) is a less invasive alternative that aims to reduce complications and simplify post-operative care. This study aimed to compare the effectiveness and safety of PF to trabeculectomy in the management of glaucoma. Methods: This was a retrospective cohort analysis of 95 eyes (48 PF, 47 trabeculectomy) from a single-center private practice in Brisbane, Australia. Data were collected from November 2017 to January 2024. Primary outcomes included intraocular pressure (IOP) and the number of medications. Secondary outcomes included best-corrected visual acuity (BCVA) and complications. Inverse probability of treatment weighting (IPTW) was applied to baseline covariates, and weighted regression and Cox proportional hazards models were then used to estimate treatment effects. Results: The two groups had comparable patient characteristics, although the PF group was older with worse visual field mean deviation. At 12 months, both procedures significantly reduced IOP and medications; however, differences were not statistically significant between groups (2.9 mmHg; 95%CI: \u22122.0, 7.9; p = 0.303, and 0.4; 95%CI: \u22120.13, 0.96; p = 0.138, respectively). The estimated probabilities of qualified success were comparable (74.9% PF vs. 72.5% trabeculectomy). Intra-operative stenting in PF eyes eliminated early post-operative hypotony. The incidence of open surgical revision in the PF group vs. the trabeculectomy group was 14.6% vs. 2.1% (p = 0.059, respectively). PF was associated with faster post-operative inflammation resolution (hazard ratio: 6.3; 95%CI: 2.8, 14.5; p &lt; 0.001). Conclusions: Both PF and trabeculectomy are effective for glaucoma management. PF is a less invasive procedure with a lower rate of early hypotony when stented. Trabeculectomy has a tendency for lower IOP reduction and less requirement for open revision, although this did not reach statistical significance. This highlights the need for longer-term studies and improved techniques, such as more effective anti-fibrotic strategies.<\/jats:p>","DOI":"10.3390\/jcm14217484","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:20:44Z","timestamp":1761196844000},"page":"7484","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Primary PreserFlo MicroShunt Versus Trabeculectomy: Effectiveness and Safety in the Real World"],"prefix":"10.3390","volume":"14","author":[{"given":"Anoushka N.","family":"Kothari","sequence":"first","affiliation":[{"name":"Mayne Academy of Surgery, University of Queensland, Brisbane, QLD 4006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A.","family":"Lee","sequence":"additional","affiliation":[{"name":"Mayne Academy of Surgery, University of Queensland, Brisbane, QLD 4006, Australia"},{"name":"Brisbane North Eye Centre, Chermside, QLD 4032, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,10,22]]},"reference":[{"key":"ref_1","first-page":"e28288","article-title":"PreserFlo\u2122 MicroShunt Versus trabeculectomy in Patients with Moderate to Advanced Open-Angle Glaucoma: 12-Month Follow-Up of a Single-Center Prospective Study","volume":"14","author":"Fili","year":"2022","journal-title":"Cureus"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s00417-023-06075-4","article-title":"PRESERFLO\u2122 MicroShunt versus trabeculectomy: 1-year results on efficacy and safety","volume":"261","author":"Jamke","year":"2023","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/aos.14968","article-title":"PRESERFLO\u2122 MicroShunt versus trabeculectomy: First results on efficacy and safety","volume":"100","author":"Pillunat","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/aos.16658","article-title":"Comparing the safety and efficacy of PreserFlo Microshunt implantation and trabeculectomy for glaucoma: A systematic review and meta-analysis","volume":"102","author":"Khan","year":"2024","journal-title":"Acta Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00417-024-06649-w","article-title":"PreserFlo MicroShunt versus trabeculectomy: An updated meta-analysis and systematic review","volume":"263","author":"Governatori","year":"2025","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Lupardi, E., Laffi, G.L., Moramarco, A., Barboni, P., and Fontana, L. (2023). Systematic PreserFlo MicroShunt Intraluminal Stenting for Hypotony Prevention in Highly Myopic Patients: A Comparative Study. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041677"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ogla.2025.03.003","article-title":"Comparative Study of Early Safety and Effectiveness Outcomes of the PreserFlo MicroShunt with and without an Intraluminal Suture Stent","volume":"8","author":"Chami","year":"2025","journal-title":"Ophthalmol. Glaucoma"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/s41433-022-01995-7","article-title":"Short-term safety and efficacy of PreserFlo\u2122 Microshunt in glaucoma patients: A multicentre retrospective cohort study","volume":"37","author":"Bhayani","year":"2023","journal-title":"Eye"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ogla.2021.07.008","article-title":"Safety and Effectiveness of the PRESERFLO\u00ae MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study","volume":"5","author":"Beckers","year":"2022","journal-title":"Ophthalmol. Glaucoma"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40123-024-01074-y","article-title":"One-Year Comparison of Efficacy and Safety of PreserFlo MicroShunt with Mitomycin C Applied by Sub-Tenon Injection Versus Sponge","volume":"14","author":"Majtanova","year":"2025","journal-title":"Ophthalmol. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Ibarz Barber\u00e1, M., L\u00f3pez-Grau, N.S., Amaro-Alc\u00e1zar, A., Morales-Fernandez, L., Garc\u00eda-Feijo\u00f3, J., and Mart\u00ednez-de-la-Casa, J.M. (2023). Bleb geometry and morphology after PreserFlo Microshunt surgery: Risk factors for surgical failure. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0286884"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Hasan, S.M., Theilig, T., and Meller, D. (2023). Comparison of Bleb Morphology following PRESERFLO\u00ae MicroShunt and trabeculectomy Using Anterior Segment OCT. Diagnostics, 13.","DOI":"10.3390\/diagnostics13213373"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1136\/bjophthalmol-2021-320631","article-title":"One-year surgical outcomes of the PreserFlo MicroShunt in glaucoma: A multicentre analysis","volume":"107","author":"Tanner","year":"2023","journal-title":"Br. J. Ophthalmol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.ophtha.2021.05.023","article-title":"Ab-Externo MicroShunt versus Trabeculectomy in Primary Open-Angle Glaucoma: One-Year Results from a 2-Year Randomized, Multicenter Study","volume":"128","author":"Baker","year":"2021","journal-title":"Ophthalmology"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Zweifel, L.A.B., Storp, J.J., Vietmeier, F.E., Eter, N., and Br\u00fccher, V.C. (2024). PreserFlo MicroShunt versus Trabeculectomy: Efficacy and Surgical Success within a Heterogenous Patient Cohort. Life, 14.","DOI":"10.3390\/life14091171"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Nobl, M., Gr\u00fcn, C., Kassumeh  , S., Priglinger, S., and Mackert, M.J. (2023). One-Year Outcomes of PreserFlo\u2122 MicroShunt Implantation versus trabeculectomy for Pseudoexfoliation Glaucoma. J. Clin. Med., 12.","DOI":"10.3390\/jcm12083000"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/IJG.0000000000001734","article-title":"Long-term Results of the PRESERFLO MicroShunt in Patients with Primary Open-angle Glaucoma from a Single-center Nonrandomized Study","volume":"30","author":"Batlle","year":"2021","journal-title":"J. Glaucoma"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40662-019-0162-1","article-title":"Ab externo implantation of the MicroShunt, a poly (styrene-block-isobutylene-block-styrene) surgical device for the treatment of primary open-angle glaucoma: A review","volume":"6","author":"Sadruddin","year":"2019","journal-title":"Eye Vis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1097\/IJG.0000000000002246","article-title":"Outcomes of Open Bleb Revision After PreserFlo MicroShunt Failure in Patients with Glaucoma","volume":"32","author":"Strzalkowska","year":"2023","journal-title":"J. Glaucoma"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Saeed, E., Go\u0142aszewska, K., Dmuchowska, D.A., Zalewska, R., and Konopi\u0144ska, J. (2023). The PreserFlo MicroShunt in the Context of Minimally Invasive Glaucoma Surgery: A Narrative Review. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20042904"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/21\/7484\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T08:25:33Z","timestamp":1761207933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/14\/21\/7484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":20,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["jcm14217484"],"URL":"https:\/\/doi.org\/10.3390\/jcm14217484","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,22]]}}}